Cover Image

Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer

Aim: This real-world study aims to compare overall survival (OS) associated with biweekly (Q2W) versus weekly (Q1W) cetuximab dosing regimens for metastatic colorectal cancer (mCRC) treatment in the US. Methods: Adult patients with KRAS wild-type mCRC who received cetuximab ± chemotherapy from 2013...

Full description

Saved in:

Bibliographic Details
Main Authors:	Himani Aggarwal (Author), Yimei Han (Author), Kristin M Sheffield (Author), Zhanglin Lin Cui (Author)
Format:	Book
Published:	Becaris Publishing Limited, 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cetuximab Can Be an Effective and Low-Toxicity Maintenance Treatment Drug in Patients With Metastatic Colorectal Cancer: A Real-World Study of Zhejiang Cancer Hospital
by: Meiqin Yuan, et al.
Published: (2021)

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer
by: Suenaga M, et al.
Published: (2015)

Association Between Regorafenib Dose and Efficacy Against Metastatic Colorectal Cancer in a Real-World Setting
by: Masahiro Hatori, et al.
Published: (2021)

Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice
by: Alistair Ring, et al.
Published: (2023)

Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by: Ningning Liu, et al.
Published: (2020)

Is more better than less? Caveats from bevacizumab and cetuximab combination in colorectal cancer
by: Camillo Porta
Published: (2011)

A Case of Punctate Psoriasis Following Treatment with Cetuximab in a Patient with Metastatic Gastric Adenocarcinoma
by: Fan J, et al.
Published: (2024)

Blefarite e tricomegalia induzidas pelo cetuximabe Blepharitis and trichomegaly induced by cetuximab
by: Paulo Ricardo Criado, et al.
Published: (2010)

Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women
by: Elza Maria Hartmann Uberti, et al.
Published: (2015)

Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study
by: Ting Deng, et al.
Published: (2023)

Salvage Chemotherapy in Recurrent Cervical Cancer With Biweekly Pegylated Liposomal Doxorubicin (Lipo-Dox)
by: Jen-Ruei Chen, et al.
Published: (2008)

Cetuximab: a standard approach to the first-line treatment of recurrent and/or metastatic and locally advanced squamous cell carcinoma of the head and neck
by: Jacques Bernier
Published: (2011)

Mifepristone in fibroids: Comparative study of safety and efficacy of biweekly dosage vs daily dosage schedule
by: Neelofar Shaikh, et al.
Published: (2021)

CASE SERIES OF PATIENTS UNDER BIWEEKLY TREATMENT WITH LARONIDASE: A REPORT OF A SINGLE CENTER EXPERIENCE
by: Sandra Obikawa Kyosen, et al.
Published: (2019)

Enhanced anticancer effect of cetuximab combined with ethanol extract of Volvariella volvacea in colorectal cancer targeted TOP2A and PPARγ
by: Sofy Permana, et al.
Published: (2024)

Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score-matched analysis of real-world data
by: Chengcheng Gong, et al.
Published: (2022)

Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients
by: Sophie Kurk, et al.
Published: (2019)

Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
by: Roy Somak, et al.
Published: (2012)

Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy
by: Wiebke Sihver, et al.
Published: (2014)

Real-World Utilization, Barriers, and Factors Associated With the Targeted Treatment of Metastatic Colorectal Cancer Patients in China: A Multi-Center, Hospital-Based Survey Study
by: Yin Liu, et al.
Published: (2023)

Outcomes of Daily Dose versus Part-daily Dose Treatment for Lung Tuberculosis: A Real-World Database Study in an Indonesian Hospital
by: William William, et al.
Published: (2021)

Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
by: Qiongwen Zhang, et al.
Published: (2023)

Near-infrared fluorescent molecular probes with cetuximab in the in vivo fluorescence imaging for epithelial ovarian cancer
by: Chen Zhang, et al.
Published: (2024)

Dermopathy associated with cetuximab and panitumumab: investigation of the usefulness of moisturizers in its management
by: Watanabe S, et al.
Published: (2017)

Pili canaliculi caused by cetuximab - A three-dimensional ultrastructural analysis
by: Hiram Larangeira de Almeida Jr, et al.
Published: (2024)

Evaluation of the Physicochemical and Biological Stability of Cetuximab under Various Stress Condition
by: Afsaneh Farjami, et al.
Published: (2019)

Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer-the Experience of a Tertiary Cancer Center
by: Călin Căinap, et al.
Published: (2021)

Immunotherapy regimens for metastatic colorectal carcinomas
by: Babar Bashir, et al.
Published: (2018)

Trifluridine/tipiracil as a therapeutic option in real life setting of metastatic colorectal cancer: An efficacy and safety analysis
by: Daniel Sur, et al.
Published: (2022)

Real-World Metastatic Renal Cell Carcinoma Treatment Patterns and Clinical Outcomes in The Netherlands
by: S.A. van Laar, et al.
Published: (2022)

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience
by: Li Y, et al.
Published: (2020)

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment
by: Donata Galbiati, et al.
Published: (2019)

Real-world experiences of folic acid supplementation (5 versus 30 mg/week) with methotrexate in rheumatoid arthritis patients: a comparison study
by: K.T. Koh, et al.
Published: (2016)

Molecularly targeted drugs for metastatic colorectal cancer
by: Cheng YD, et al.
Published: (2013)

A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma
by: Hansoo Kim, et al.
Published: (2018)

Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinoma
by: Anna Maria Rachiglio, et al.
Published: (2020)

A randomized crossover study of single biweekly administration of epoetin-α compared with darbepoetin-α in chronic kidney disease patients not receiving dialysis
by: Ha-Young Na, et al.
Published: (2014)

Use of Cetuximab in Combination with Cisplatin and Adjuvant Pelvic Radiation for Stage IIIB Vulvar Carcinoma
by: Jennifer Bergstrom, et al.
Published: (2015)

Comprehensive Analysis of Cetuximab Critical Quality Attributes: Impact of Handling on Antigen-Antibody Binding
by: Alicia Torres-García, et al.
Published: (2024)

A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab
by: Madelyn Espinosa-Cotton, et al.
Published: (2019)